Company Overview

Update
IPO:
Went Public on Jun 25, 2002
Stock:
BDSIU
Categories:
Biotechnology
Description:
BioDelivery Sciences is a specialty pharmaceutical company focusing on pain management and addiction medicine.

Detailed Description

Update

BioDelivery Sciences ("BDSI"®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. They are utilizing their novel and proprietary BioErodible MucoAdhesive (BEMA®) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.

Current Team (10)

Update

Past Team (6)

Update

Funding Rounds (2) - $60M

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Headquarters

    801 Corporate Center Drive

    Suite 210

    Raleigh, 27607

Images (1)

Update
  • 4018567236a3bcb5877aa8e9b09a33b2